$BIIB Analysts’ Actions

0
580
Biotech Stocks

Analysts’ Actions: Biogen Idec, Darden, Nvidia and More

By TheStreet Staff

Biogen Idec was downgraded to hold from buy at Stifel. Valuation call, as some potential risks loom on the horizon, Stiefel said.

CatchMark Timber Trust was upgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: CTT Ratings Report.

Darden Restaurants was upgraded at Telsey Advisory to market perform from outperform. Twelve-month price target is $77. Estimates were also increased as the company is cutting costs, Telsey Advisory said.

Nvidia was downgraded at Goldman Sachs to sell from neutral. Twelve-month price target is $20. Company is seeing slower core demand and faces a licensing risk, Goldman Sachs said.

Carnival was downgraded at Deutsche Bank to hold from buy. Twelve-month price target is $51. Company is facing material currency risks, Deutsche Bank said.

EMC was downgraded at Piper Jaffray to neutral from overweight. Twelve-month price target is $27. Company is facing increased competition, Piper Jaffray said.

NetApp was downgraded at Piper Jaffray to neutral from overweight. Twelve-month price target is $36. Estimates were also cut, as the company is facing increased competition, Piper Jaffray said.

Unit was downgraded to sell at TheStreet Ratings. You can view the full analysis from the report here: UNT Ratings Report.

Must Read: 10 Stocks Carl Icahn Loves for 2015: Apple, eBay, Hertz and More

Editor’s note: To see analysts’ stock comments and changes to price targets and earnings estimates, go to “Street Notes,” which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.

Follow TheStreet on Twitter and become a fan on Facebook.

LEAVE A REPLY

Please enter your comment!
Please enter your name here